Effect of left ventricular ejection fraction Spectrum on 1‐Year mortality in patients with acute ischemic stroke or transient ischemic attack

Author:

Wei Na12ORCID,Wei Yufei12ORCID,Nie Ximing12,Liu Xiran12,Xiang Xianglong12,Pan Yuesong12,Meng Xia12,Liu Liping12,Wang Yongjun12

Affiliation:

1. Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China

2. China National Clinical Research Center for Neurological Diseases Beijing China

Abstract

AbstractAimsWe aimed to investigate the association of the left ventricular ejection fraction (LVEF) spectrum with 1‐year clinical outcomes in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).MethodsIn a prospective registry for the Third China National Stroke Registry (CNSR‐III), AIS or TIA patients with echocardiography records during hospitalization were recruited. All LVEFs were categorized into intervals of 5% in width. The lowest and highest intervals are ≤40% and >70%, respectively. The primary outcome was all‐cause death at 1 year. Cox proportional hazards regression analysis was performed to investigate the association between baseline LVEF and clinical outcomes.ResultsThis analysis included a total of 14,053 patients. In total, 418 patients died during 1‐year follow‐up. Overall, LVEF ≤60% was associated with a higher risk of all‐cause death compared to LVEF >60%, independent of demographic and clinical characteristics (aHR 1.29 [95% CI 1.06–1.58]; p = 0.01). The cumulative incidence of all‐cause death was significantly different among the eight LVEF groups that survival declined successively with the decrease of LVEF (log‐rank p ≤ 0.0001).ConclusionsPatients with AIS or TIA with decreased LVEF (≤60%) had a lower 1‐year survival rate after onset. LVEF 50%–60% even within the normal range, may still contribute to poor outcomes in AIS or TIA. Comprehensive evaluation of cardiac function after acute ischemic cerebrovascular disease should be strengthened.

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3